布瑞哌唑

布瑞哌唑（CAS 913611-97-9）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的理化数值

在册的记载用途

Brexpiprazole is indicated as adjunctive therapy to antidepressants for the treatment of major depressive disorder in adults. It is also indicated for the treatment of schizophrenia in patients 13 years of age and older. Brexpiprazole is also indicated for the treatment of agitation associated with dementia due to Alzheimer’s disease; however, it is not indicated as an as-needed (“prn”) treatment for this condition.Brexpiprazole is an atypical antipsychotic used in the treatment of schizophrenia and major depressive disorders. Brexpiprazole has been associated with a low rate of serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent acute liver injury.

同义词与商品名

BREXPIPRAZOLE; 913611-97-9; Rexulti; OPC-34712; OPC 34712; brexpiprazol; 7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one; 2J3YBM1K8C; 7-(4-(4-(1-Benzothiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one; DTXSID40238527; 7-{4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy}-1,2-dihydroquinolin-2-one; brexpiprazolum; 7-(4-(4-(1-benzothiophen-4-yl)piperazin-1-yl)butoxy)-1H-quinolin-2-one; 7-{4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one; 7-(4-(4-(1-benzothiophen-4-yl)piperazin-1-yl)butoxy)-1,2-dihydroquinolin-2-one; RefChem:58868

GHS 危害分类

Reported hazard statements	H302 (96.6%), H351 (98.3%), H360 (96.6%), H362 (98.3%), H372 (96.6%), H400 (96.6%), H410 (98.3%), H361 (100%)

H302 (96.6%): Harmful if swallowed [Warning Acute toxicity, oral]

H351 (98.3%): Suspected of causing cancer [Warning Carcinogenicity]

公开数据库对它的描述

Brexpiprazole · CAS 913611-97-9 · C25H27N3O2S. UNII 2J3YBM1K8C. Boiling Point: 675.2; Melting Point: 135.1.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。